Amygdala Neurofeedback

DEVICE3 trials

Sponsors

Kymberly Young, Central Institute of Mental Health, Mannheim

Conditions

Borderline Personality DisorderTreatment Resistant Depression

Phase 1

Brain Signal Training to Enhance Affect Down-regulation

RecruitingNCT06626789

Central Institute of Mental Health, MannheimBorderline Personality Disorder

Start: 2025-04-23End: 2028-06-01Target: 164Updated: 2026-02-03

Unknown Phase

Neurofeedback for Treatment Resistant Depression

CompletedNCT03428828

Kymberly YoungTreatment Resistant Depression

Start: 2018-10-22End: 2026-03-01Updated: 2026-03-04

Neurofeedback for Borderline Personality Disorder

Active, not recruitingNCT05398627

Kymberly YoungBorderline Personality Disorder

Start: 2022-09-02End: 2026-04-30Target: 100Updated: 2025-11-12

Related Papers

A randomised controlled trial of amygdala fMRI-neurofeedback versus sham-feedback in borderline-personality disorder - systematic literature review and introduction to the BrainSTEADy trial.

2025-07-08

Amygdala real-time fMRI neurofeedback upregulation in treatment resistant depression: Proof of concept and dose determination

Behaviour Research and Therapy2024-03-1511 citations